Pharmaceuticals

Our Pharmaceuticals portfolio includes 500+ reports on prescription and over-the-counter medications. We track small molecule drugs, biologics, generics, and consumer health products across therapeutic categories and formulation types.

>
>

Industry Overview

The global pharmaceuticals business is one of the most crucial and fastest-growing healthcare industries, fueled by aging populations, rising rates of chronic diseases, and ongoing innovation in drug formulation and manufacturing technology. India's pharmaceutical industry was worth USD 50 billion in FY 2023u201324, with USD 23.5 billion representing domestic consumption and USD 26.5 billion in exports, as per government statistics. This large market is comprised of several distinct categories and market segments, including active pharmaceutical ingredients, clinical nutrition, medicines for specific diseases, drug delivery systems, finished drugs, pharmaceutical excipients, manufacturing processes, and vaccines; all of which are critical healthcare and regulatory needs in global markets. rn

The active pharmaceutical ingredients segment is the backbone of pharmaceutical production, where the market was worth more than USD 228.5 billion in 2022 and is projected to grow at over 6.5% CAGR during the period from 2023 to 2032 due to expanding demand for drugs and treatment of rare diseases. Targeted segments of APIs exhibit impressive growth, such as high potency active pharmaceutical ingredients market worth USD 27.1 billion in 2024 and projected to advance at a 8.8% CAGR during 2025-2034 and small molecule API market worth USD 194.7 billion in 2024 and projected to advance at a 5.8% CAGR during 2025-2034, with escalating incidence of chronic diseases.

Major drivers for the market are increasing healthcare spending, regulatory convergence globally, patent losses giving rise to generic opportunities, and technological innovation in precision medicine, biologics, and personalized therapeutics. The overall sector benefits from substantial research and development investment, continued growth in contract manufacturing, and expanded market access in growing emerging economies. The digitization of the sector and the incorporation of AI-assisted drug discovery and next generation manufacturing technologies are fundamentally changing the efficacy and efficiency of the development, manufacturing, and regulatory compliance of ALL categories and market segments in pharmaceutical development and manufacturing.

Trusted by Industry Leaders

Partnering with global enterprises and backed by industry certifications for excellence and security

Logo 0
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Logo 8
Logo 9
Logo 10
Logo 11
Logo 12
Logo 0
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Logo 8
Logo 9
Logo 10
Logo 11
Logo 12
Logo 0
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Logo 8
Logo 9
Logo 10
Logo 11
Logo 12
img
Request Our Portfolio
country Flag
+1
img

Request Our Portfolio

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential

Thank you for your inquiry. Our team will contact you via email with the necessary details. Please also check your spam folder to ensure you don't miss our response.

Latest Market Reports

Our market research reports and services provide a roadmap to your next success

Industries

    • Showing 50 records out of 597

    Showing 50 records out of 597 on Page 1 of 12

    Cited by Leading Publications

    Global Market Insights citation in Investing
    Global Market Insights featured in Business Insider
    Global Market Insights citation in BBC
    Global Market Insights featured in National Geographic
    Global Market Insights featured in Times of India, Indiatimes
    Global Market Insights citation in CNBC